Clincosm LogoSign in Get a demo

postmenopausal

Showing 1 - 25 of 45
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Postmenopausal, Prediabetes, Adolescent and Young Adult (AYA) Cancer Survivors Trial (Glucose-Guided Eating with CGM, CGM only)

Not yet recruiting
  • Postmenopausal
  • +2 more
  • Glucose-Guided Eating with CGM
  • CGM only
  • (no location specified)
Aug 16, 2023

Postmenopausal Trial in Rochester (Mindfulness Audio Recordings)

Recruiting
  • Postmenopausal
  • Mindfulness Audio Recordings
  • Rochester, Minnesota
    Mayo Clinic Rochester
Jan 9, 2023

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

Postmenopausal, Hypertension Trial (Short set configuration resistance training, Long set configuration resistance training)

Not yet recruiting
  • Postmenopausal
  • Hypertension
  • Short set configuration resistance training
  • Long set configuration resistance training
  • (no location specified)
Sep 14, 2022

Dose-Response to Exercise in Women Aged 45-75 Years (DREW)

Completed
  • Cardiovascular Diseases
  • +3 more
  • Exercise
  • Dallas, Texas
  • +1 more
Sep 13, 2022

Postmenopausal Trial in Xuzhou (HLX14, Prolia®)

Recruiting
  • Postmenopausal
  • HLX14
  • Prolia®
  • Xuzhou, Jiangsu, China
    Affiliated Hospital of Xuzhou Medical University
Jul 8, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +15 more
  • Dietary Intervention
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jun 23, 2022

Postmenopausal, Postmenopausal Flushing Trial in Berne (Iyengar Yoga)

Suspended
  • Postmenopausal
  • Postmenopausal Flushing
  • Iyengar Yoga
  • Berne, Switzerland
    Dep. of Obstetrics and Gynecology, Bern University Hospital, Ber
Mar 29, 2022

Cancer Survivor, Estrogen Receptor-positive Breast Cancer, Stage IA Breast Cancer Trial in Duarte (exercise intervention,

Active, not recruiting
  • Cancer Survivor
  • +7 more
  • exercise intervention
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Breast Carcinoma, Cervical Carcinoma, Ovarian Carcinoma Trial in United States (Bupropion 150 mg XL, Placebo)

Completed
Has Results
  • Breast Carcinoma
  • +6 more
  • Bupropion 150 mg XL
  • Placebo
  • Anaheim, California
  • +361 more
Feb 10, 2022

Postmenopausal, Insulin Resistance Trial in Mexico City (vitamin C (500 mg / day) + , resveratrol (500 mg / day) + , vitamin C

Active, not recruiting
  • Postmenopausal
  • Insulin Resistance
  • vitamin C (500 mg / day) + placebo
  • +2 more
  • Mexico City, Mexico
    Instituto Nacional de Perinatología Isidro Espinosa de los Reyes
Dec 24, 2021

Malignant Tumor, Postmenopausal Trial in Portland (Exercise Intervention, Questionnaire Administration)

Completed
  • Malignant Neoplasm
  • Postmenopausal
  • Exercise Intervention
  • Questionnaire Administration
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 20, 2021

Postmenopausal Trial (lumbar stabilization exercises)

Not yet recruiting
  • Postmenopausal
  • lumbar stabilization exercises
  • (no location specified)
Aug 14, 2021

Ductal Breast Carcinoma In Situ, Postmenopausal Trial in United States (drug, other, procedure)

Recruiting
  • Ductal Breast Carcinoma In Situ
  • Postmenopausal
  • Conjugated Estrogens/Bazedoxifene
  • +5 more
  • Aurora, Colorado
  • +9 more
May 27, 2021

Advanced Malignant Solid Tumor, Estrogen Receptor Positive, HER2/Neu Positive Trial in United States (drug, other, biological)

Completed
  • Advanced Malignant Solid Neoplasm
  • +12 more
  • Houston, Texas
  • +4 more
Dec 16, 2020

Healthy, Obesity, Postmenopausal Trial in Columbus (communication intervention, exercise intervention)

Completed
  • Healthy
  • +2 more
  • communication intervention
  • exercise intervention
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 26, 2020

Overweight, Postmenopausal Trial in Bellerive-sur-Allier (Moderate Intensity Continuous Exercise, High-Intensity Interval

Completed
  • Overweight
  • Postmenopausal
  • Moderate Intensity Continuous Exercise
  • +2 more
  • Bellerive-sur-Allier, Allier, France
    CREPS Auvergne Rhône-Alpes / Vichy
Apr 26, 2020

Hot Flash, Stellate Ganglion Block, Postmenopausal Trial in Arnhem (Bupivacaine block, Placebo ganglion block)

Completed
  • Hot Flash
  • +3 more
  • Bupivacaine block
  • Placebo ganglion block
  • Arnhem, Netherlands
    Rijnstate hospital
Mar 10, 2020

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, KIT Positive Trial in Houston (Imatinib Mesylate,

Completed
Has Results
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 14, 2020

Ductal Breast Carcinoma, Ductal Breast Carcinoma In Situ, Estrogen Receptor Negative Trial in Buffalo (Broccoli Sprout Extract,

Completed
  • Ductal Breast Carcinoma
  • +10 more
  • Broccoli Sprout Extract
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 29, 2019

Cancer Survivor, Central Obesity, Estrogen Receptor Positive Trial in Los Angeles (Exercise Intervention, Informational

Withdrawn
  • Cancer Survivor
  • +14 more
  • Exercise Intervention
  • +4 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Oct 21, 2019

Postmenopausal, Overweight and Obesity Trial in Boone (Watermelon)

Completed
  • Postmenopausal
  • Overweight and Obesity
  • Watermelon
  • Boone, North Carolina
    Appalachian State University
Jul 8, 2019

Postmenopausal, Osteopenia Trial (Romosozumab, Placebo)

Completed
Has Results
  • Postmenopausal
  • Osteopenia
  • (no location specified)
Apr 10, 2019

Metastatic ER+ Her2- Breast Cancer, Postmenopausal Trial in Worldwide (Exemestane, Abiraterone acetate + Prednisone/

Completed
Has Results
  • Metastatic ER+ Her2- Breast Cancer
  • Postmenopausal
  • Muscle Shoals, Alabama
  • +84 more
Mar 28, 2019

HER2/Neu Negative, Invasive Breast Carcinoma, Postmenopausal Trial in Seattle (Anastrozole, Exemestane, Laboratory Biomarker

Withdrawn
  • HER2/Neu Negative
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 26, 2018